Solution structure of the major G-quadruplex formed in the human VEGF promoter in K+: Insights into loop interactions of the parallel G-quadruplexes

Nucleic Acids Research

Volumn 41, Issue 22, 2013, Pages 10584-10592

  Agrawal, Prashansa ^a   Hatzakis, Emmanuel ^a   Guo, Kexiao ^a   Carver, Megan ^a   Yang, Danzhou ^a,b,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b University of Arizona   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE QUADRUPLEX; POTASSIUM ION; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CHEMICAL STRUCTURE; CONTROLLED STUDY; DNA STRAND; DNA STRUCTURE; GENE REPRESSION; HUMAN; HUMAN CELL; MEMBRANE STABILIZATION; MOLECULAR LIBRARY; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FOLDING;

G-QUADRUPLEXES; HUMANS; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; POTASSIUM; PROMOTER REGIONS, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84890389008     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt784     Document Type: Article

References (50)

1. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E.N., Moore, D.H., Meli, S. and Gasparini, G. (1992) Tumor angiogenesis- A new significant and independent prognostic indicator in earlystage breast-carcinoma. J. Natl Cancer Inst., 84, 1875-1887.
2. Ferrara, N. (1996) Vascular endothelial growth factor. Eur. J. Cancer, 32A, 2413-2422.
3. Folkman, J. (2002) Role of angiogenesis in tumor growth and metastasis. Semin. Oncol., 29, 15-18.
4. Jain, R.K. (2002) Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. Semin. Oncol., 29, 3-9.
5. Schafer, G., Cramer, T., Suske, G., Kemmner, W., Wiedenmann, B. and Hocker, M. (2003) Oxidative stress regulates vascular endothelial growth factor- A gene transcription through Sp1-and Sp3-dependent activation of two proximal GC-rich promoter elements. J. Biol. Chem., 278, 8190-8198.
6. Maeno, T., Tanaka, T., Sando, Y., Suga, T., Maeno, Y., Nakagawa, J., Hosono, T., Sato, M., Akiyama, H., Kishi, S. et al. (2002) Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells. Am. J. Respir. Cell Mol. Biol., 26, 246-253.
7. Chen, H.Z., Ye, D.F., Xie, X., Chen, B.Y. and Lu, W.G. (2004) VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma. Gynecol. Oncol., 94, 630-635.
8. Shi, Q., Le, X.D., Abbruzzese, J.L., Peng, Z.H., Qian, C.N., Tang, H.M., Xiong, Q.H., Wang, B.L., Li, X.C. and Xie, K.P. (2001) Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res., 61, 4143-4154.
9. Pal, S., Datta, K. and Mukhopadhyay, D. (2001) Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Cancer Res., 61, 6952-6957.
10. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B. and Marme, D. (1995) Both V-Ha-Ras and V-Raf stimulate expression of the vascular endothelial growth-factor in Nih 3t3 Cells. J. Biol. Chem., 270, 25915-25919.
11. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D. and Semenza, G.L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol.Cell Biol., 16, 4604-4613.
12. Cohen, T., Nahari, D., Cerem, L.W., Neufeld, G. and Levi, B.Z. (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem., 271, 736-741.
13. Finkenzeller, G., Sparacio, A., Technau, A., Marme, D. and Siemeister, G. (1997) Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene, 15, 669-676.
14. Martinybaron, G. and Marme, D. (1995) Vegf-mediated tumor angiogenesis- A new target for cancer-therapy. Curr. Opin. Biotechnol., 6, 675-680.
15. Ellis, L.M. and Hicklin, D.J. (2008) VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer, 8, 579-591.
16. Eichholz, A., Merchant, S. and Gaya, A.M. (2010) Antiangiogenesis therapies: their potential in cancer management. OncoTargets Ther., 3, 69-82.
17. Bikfalvi, A. and Bicknell, R. (2002) Recent advances in angiogenesis, anti-angiogenesis and vascular targeting. Trends Pharmacol. Sci., 23, 576-582.
18. Sepp-Lorenzino, L. and Thomas, K.A. (2002) Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development. Expert Opin. Investig. Drugs, 11, 1447-1465.
19. Niederman, T.M.J., Ghogawala, Z., Carter, B.S., Tompkins, H.S., Russell, M.M. and Mulligan, R.C. (2002) Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors. Proc. Natl Acad. Sci. USA, 99, 7009-7014.
20. Jin, N., Chen, W., Blazar, B.R., Ramakrishnan, S. and Vallera, D.A. (2002) Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factorimmunotoxin target gene. Hum. Gene Ther., 13, 497-508.
21. Goodman, V.L., Rock, E.P., Dagher, R., Ramchandani, R.P., Abraham, S., Gobburu, J.V.S., Booth, B.P., Verbois, S.L., Morse, D.E., Liang, C.Y. et al. (2007) Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma. Clin. Cancer Res., 13, 1367-1373.
22. Kane, R.C., Farrell, A.T., Saber, H., Tang, S., Williams, G., Jee, J.M., Liang, C., Booth, B., Chidambaram, N., Morse, D. et al. (2006) Sorafenib for the treatment of advanced renal cell carcinoma. Clin. Cancer Res., 12, 7271-7278.
23. Ferrara, N., Hillan, K.J., Gerber, H.P. and Novotny, W. (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat. Rev. Drug Discov., 3, 391-400.
24. Balasubramanian, S., Hurley, L.H. and Neidle, S. (2011) Targeting G-quadruplexes in gene promoters: a novel anticancer strategy Nat. Rev. Drug Discov., 10, 261-275.
25. Brooks, T.A. and Hurley, L.H. (2010) Targeting MYC expression through G-quadruplexes. Genes Cancer, 1, 641-649.
26. Yang, D.Z. and Okamoto, K. (2010) Structural insights into G-quadruplexes: towards new anticancer drugs. Future Med. Chem., 2, 619-646.
27. Biffi, G., Tannahill, D., McCafferty, J. and Balasubramanian, S. (2013) Quantitative visualization of DNA G-quadruplex structures in human cells. Nat. Chem., 5, 182-186.
28. Sun, D.Y., Guo, K.X., Rusche, J.J. and Hurley, L.H. (2005) Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and Gquadruplex-interactive agents. Nucleic Acids Res., 33, 6070-6080.
29. Guo, K., Gokhale, V., Hurley, L.H. and Sun, D. (2008) Intramolecularly folded G-quadruplex and i-motif structures in the proximal promoter of the vascular endothelial growth factor gene. Nucleic Acids Res., 36, 4598-4608.
30. Sun, D., Guo, K. and Shin, Y.J. (2011) Evidence of the formation of G-quadruplex structures in the promoter region of the human vascular endothelial growth factor gene. Nucleic Acids Res., 39, 1256-1265.
31. Sun, D., Liu, W.J., Guo, K.X., Rusche, J.J., Ebbinghaus, S., Gokhale, V. and Hurley, L.H. (2008) The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplexinteractive agents. Mol.Cancer Ther., 7, 880-889.
32. Chen, Y. and Yang, D.Z. (2012) Sequence, stability, and structure of G-quadruplexes and their interactions with drugs. Curr. Protoc. Nucleic Acid Chem., 50, 17.15.11-17.15.17.
33. Dai, J., Dexheimer, T.S., Chen, D., Carver, M., Ambrus, A., Jones, R.A. and Yang, D.Z. (2006) An intramolecular Gquadruplex structure with mixed parallel/antiparallel G-strands formed in the human BCL-2 promoter region in solution. J. Am. Chem. Soc., 128, 1096-1098.
34. Dai, J., Carver, M., Punchihewa, C., Jones, R.A. and Yang, D.Z. (2007) Structure of the Hybrid-2 type intramolecular human telomeric G-quadruplex in K+solution: insights into structure polymorphism of the human telomeric sequence. Nucleic Acids Res., 35, 4927-4940.
35. Ambrus, A., Chen, D., Dai, J., Jones, R.A. and Yang, D.Z. (2005) Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization. Biochemistry, 44, 2048-2058.
36. Zhang, Z., Dai, J., Veliath, E., Jones, R.A. and Yang, D.Z. (2010) Structure of a two-G-tetrad intramolecular G-quadruplex formed by a variant human telomeric sequence in K+solution: insights into the interconversion of human telomeric G-quadruplex structures. Nucleic Acids Res., 38, 1009-1021.
37. Mathad, R.I., Hatzakis, E., Dai, J. and Yang, D.Z. (2011) c-MYC promoter G-quadruplex formed at the 50-end of NHE III1 element: insights into biological relevance and parallel-stranded G-quadruplex stability. Nucleic Acids Res., 39, 9023-9033.
38. Hatzakis, E., Okamoto, K. and Yang, D.Z. (2010) Thermodynamic stability and folding kinetics of the major g-quadruplex and its loop isomers formed in the nuclease hypersensitive element in the human c-Myc promoter: effect of loops and flanking segments on the stability of parallel-stranded intramolecular G-quadruplexes. Biochemistry, 49, 9152-9160.
39. Ambrus, A., Chen, D., Dai, J., Bialis, T., Jones, R.A. and Yang, D.Z. (2006) Human telomeric sequence forms a hybrid-type intramolecular G-quadruplex structure with mixed parallel/antiparallel strands in potassium solution. Nucleic Acids Res., 34, 2723-2735.
40. Szewczak, A.A., Kellogg, G.W. and Moore, P.B. (1993) Assignment of NH resonances in nucleic acids using natural abundance 15N-1H correlation spectroscopy with spin-echo and gradient pulses. FEBS Lett., 327, 261-264.
41. Zhao, H., Pagano, A.R., Wang, W.M., Shallop, A., Gaffney, B.L. and Jones, R.A. (1997) Use of a C-13 atom to differentiate two N-15-labeled nucleosides. Syntheses of [(NH2)-N-15]-adenosine, [1, NH2-N-15(2)]-and [2-C-13-1, NH2-N-15(2)]-guanosine, and [1, 7, NH2-N-15(3)]-and [2-C-13-1, 7, NH2-N-15(3)]-2'-deoxyguanosine. J. Org. Chem., 62, 7832-7835.
42. Sklenar, V. and Bax, A. (1987) Spin-echo water suppression for the generation of pure-phase two-dimensional NMR spectra. J. Magn. Reson., 74, 469-479.
43. Brunger, A.T. (1993) X-PLOR Version 3.1: A System for X-ray Crystallography and NMR. Yale University Press, New Haven, CT.
44. Seenisamy, J., Rezler, E.M., Powell, T.J., Tye, D., Gokhale, V., Joshi, C.S., Siddiqui-Jain, A. and Hurley, L.H. (2004) The dynamic character of the G-quadruplex element in the c-MYC promoter and modification by TMPyP4. J. Am. Chem. Soc., 126, 8702-8709.
45. Phan, A.T., Modi, Y.S. and Patel, D.J. (2004) Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter. J. Am. Chem. Soc., 126, 8710-8716.
46. De Armond, R., Wood, S., Sun, D.Y., Hurley, L.H. and Ebbinghaus, S.W. (2005) Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1 alpha promoter. Biochemistry, 44, 16341-16350.
47. Fernando, H., Reszka, A.P., Huppert, J., Ladame, S., Rankin, S., Venkitaraman, A.R., Neidle, S. and Balasubramanian, S. (2006) A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene. Biochemistry, 45, 7854-7860.
48. Guo, K., Pourpak, A., Beetz-Rogers, K., Gokhale, V., Sun, D. and Hurley, L.H. (2007) Formation of pseudosymmetrical Gquadruplex and i-motif structures in the proximal promoter region of the RET oncogene. J. Am. Chem. Soc., 129, 10220-10228.
49. Palumbo, S.L., Ebbinghaus, S.W. and Hurley, L.H. (2009) Formation of a unique end-to-end stacked pair of GQuadruplexes in the hTERT core promoter with implications for inhibition of telomerase by G-Quadruplex-interactive ligands. J. Am. Chem. Soc., 131, 10878-10891.
50. Lim, K.W., Lacroix, L., Yue, D.J.E., Lim, J.K.C., Lim, J.M.W. and Phan, A.T. (2010) Coexistence of two distinct G-Quadruplex conformations in the hTERT promoter. J. Am. Chem. Soc., 132, 12331-12342.